Editorial Comment from Dr Togo to Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Abstract:
      An editorial is presented about a study about the effectiveness of fosfomycin in treating quinolone-resistant Escherichia coli diseases such as prostate cancer. It mentions that the study suggests the usefulness of the treatment when choosing a prophylactic antibacterial drug along with association of rectal swabbing.